Nuzenio

Class Centanafadine

Class Centanafadine news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 14 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 00:15:45 GMTADHD: First New Drug Class in Decades Gets FDA Approval - denkstrom.org
Fri, 07 Aug 2026 14:40:03 GMTWill Newly Approved Centanafadine Transform ADHD Care? - Physician's Weekly
Wed, 05 Aug 2026 15:24:22 GMTCentanafadine Gains FDA Approval for ADHD Across Age Groups - Patient Care Online
Mon, 03 Aug 2026 16:09:45 GMTFDA Approves First-in-Class Centanafadine for ADHD in Adults and Pediatric Patients - Pharmacy Times
Fri, 31 Jul 2026 16:39:39 GMTA New Mechanism for ADHD: Raman Baweja, MD, on Centanafadine's FDA Approval - Psychiatric Times
Wed, 29 Jul 2026 07:00:00 GMTCentanafadine Receives FDA Approval for the Treatment of ADHD - ADDitude

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Class Centanafadine.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.